Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05216406 · ClinicalTrials.gov registry record · NA
Effects of Daily Supplementation of 5-HTP on Body Composition
A NA study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT05216406 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 65 participants.
The verdict
NCT05216406, a NA study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this investigation was to compare supplementation with 5-HTP to placebo on indices of body composition. A randomized trial compared a sample of 48 resistance-trained individuals taking either 100 mg of 5-hydroxytryptophan supplementation or a placebo. The investigators tested anthropometric measurements using a multi-frequency bioelectrical impedance device (InBody® 270). The primary outcome (i.e., changes in anthropometric measurements) was assessed at the first visit (pre-test-) and post-test (8 weeks). Secondary outcomes include resting heart rate, blood pressure, and dietary intake.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT 5-HTP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05216406
The ClinicalTrials.gov registry entry for NCT05216406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05216406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05216406 about?
NCT05216406 is a clinical study titled "Effects of Daily Supplementation of 5-HTP on Body Composition". The purpose of this investigation was to compare supplementation with 5-HTP to placebo on indices of body composition. A randomized trial compared a sample of 48 resistance-trained individuals taking either 100 mg of 5-hydroxytryptophan supplementation or a placebo. The investigators tested anthrop...
What is the current status of trial NCT05216406?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2021-01-01. Estimated completion is 2021-05-15.
What interventions are being tested in trial NCT05216406?
The interventions under investigation include: Placebo (OTHER), 5-HTP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05216406?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.